Antigen testing can be paid by medical insurance account, or reimbursement policies such as "long-term prescription" and Internet diagnosis and treatment will be implemented!

The National Medical Insurance Administration has made it clear that the new crown antigen detection reagents and corresponding testing items will be temporarily included in the medical service project catalogue of medical insurance in each province; the new crown treatment drugs included in the medical insurance will be adjusted in time.
For tablets/ritonavir tablets, medical institutions shall purchase at the price agreed upon by the manufacturer and relevant departments, and the medical insurance department shall pay according to regulations
.
At the same time, the price policy of nucleic acid and antigen testing items may implement settlement and reimbursement policies such as "long-term prescription" and Internet diagnosis and treatment
.
On March 21, the Office of the National Medical Security Administration issued the "Notice on Effectively Doing a Good Job in Medical Security for Current Epidemic Prevention and Control"
.
The notice on the adjustment of new crown treatment drugs included in the scope of medical insurance payment pointed out that for the newly added drugs in the "Diagnosis and Treatment Plan (Trial Version 9)", each provincial medical security department shall refer to the "National Medical Security Administration and Ministry of Finance on Doing a Good Job in Pneumonia Infected by Novel Coronavirus" According to the relevant requirements of the “Notice of Epidemic Medical Insurance” (Guojianbaodian [2020] No.
5), it shall be temporarily included in the scope of payment of the provincial medical insurance fund; for the “Diagnosis and Treatment Plan (Trial Version 9)” which is not included in the basic medical insurance catalogue All provincial medical security departments should stop medical insurance payment from the date of the publication of the "Diagnosis and Treatment Plan (Ninth Edition for Trial Implementation)"
.
All provincial medical security departments should do a good job of listing new drugs on the Internet.
For drugs that have not been listed on the Internet, medical institutions are allowed to purchase offline first for emergency use
.
The newly added naimatevir tablets/ritonavir tablets in the "Diagnosis and Treatment Plan (Trial Version 9)" shall be purchased by medical institutions at the price agreed between the enterprise and relevant departments, and the medical insurance department shall pay according to regulations
.
Temporary inclusion of novel coronavirus antigen detection reagents into the medical insurance notice proposed that the novel coronavirus antigen detection reagents and corresponding testing items should be temporarily included in the province's basic medical insurance medical service item catalog according to procedures
.
The relevant expenses incurred by the insured in the designated primary medical institutions shall be paid in accordance with the current regulations of the overall planning area, and the expenses of purchasing testing reagents in the designated retail pharmacies can be paid using the personal account
.
All provincial medical security departments shall continue to standardize and optimize public medical institutions with reference to the "Letter of the Office of the National Medical Security Administration on Opinions on Local Proposed Temporary New Coronavirus Antigen Testing Items and Related Matters" (Medical Insurance Office Letter [2022] No.
11) Pricing policy for providing COVID-19 antigen testing services
.
Centralized pharmaceutical procurement agencies in various places should do a good job in the online purchase of novel coronavirus antigen detection reagents, actively promote online purchases, and rely on the unified national medical insurance information platform for information sharing
.
At the same time, it will strengthen the calculation and monitoring, and coordinate the promotion of price, procurement, payment and information system transformation
.
Nucleic acid and antigen testing, the implementation of "long-term prescription", Internet diagnosis and treatment and other reimbursement policy notification requirements, medical security departments at all levels should follow the "Notice of the National Medical Security Administration and the Ministry of Finance on Doing a Good Job in Medical Insurance for Pneumonia Infected by Novel Coronavirus" (National Medical insurance report [2020] No.
5) and other series of documents require, refine and improve work measures, and continue to implement policies such as comprehensive protection of medical expenses for diagnosed patients
.
Support the normal operation of medical institutions in severely affected areas, and prepay part of the new crown treatment funds according to procedures if necessary
.
Do a solid job in ensuring the cost of new coronavirus vaccines and vaccinations, conscientiously implement the price policy for nucleic acid and antigen testing items, implement "long-term prescription", Internet diagnosis and treatment and other settlement and reimbursement policies, ensure the implementation of various epidemic prevention and control medical security policies, and reduce the number of insured patients The number of visits to medical institutions for dispensing medicines can effectively reduce the safety risk of the spread of the epidemic
.
The National Medical Insurance Administration approved the total cost of antigen testing services in Henan and Chongqing to be capped at 15 yuan/time.
On March 22, the Office of the National Medical Security Administration issued a "Letter on Local Proposed Temporary New Coronavirus Antigen Testing Items and Opinions on Related Matters" ", agreed to temporarily add "new coronavirus antigen testing" price items in Henan and Chongqing, each time 5 yuan; antigen testing reagents (including sampling equipment) are sold at zero mark-up; public medical institutions carry out antigen testing services in accordance with "price items + "Test reagents" method
.
The document pointed out that the temporary new coronavirus antigen detection project is generally in line with the reform direction of "separation of technology consumption and output orientation", fully considering the technical characteristics of antigen detection, and at the same time adapting to the needs of epidemic prevention and control and promoting the fairness and availability of antigen detection.
and effective measures to reduce the social and economic burden
.
It is clarified that if the total cost of a single novel coronavirus antigen testing service and reagents (including sampling equipment) exceeds 15 yuan per time, the actual charge will be capped at 15 yuan per time; if the masses simply test antigens, public medical institutions will exempt outpatient examination fees; For patients taking self-tests, public medical institutions are not allowed to charge price policies such as the cost of "novel coronavirus antigen test" items
.
The document also requires the medical insurance bureaus of the two places to conduct special price monitoring on the prices of antigen detection reagents sold by retail terminals such as online platforms and social pharmacies in the province, and regularly notify the price supervision and inspection law enforcement departments of the retail terminal prices of antigen detection reagents and the centralized procurement prices of public medical institutions.
, take the initiative to provide the price supervision and inspection law enforcement departments with clues about unfair high prices through different channels, and actively cooperate with the inspection and law enforcement work carried out by the departments in accordance with the law
.